Delivery Order 36C25721D0091-36C25723N0340
Award Date 8/1/23
Potential Completion Date 7/31/24
Potential Value $120K
Federal Agency
Ultimate Awardee
NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Jamestown, NY 14701, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed price call order awarded by the U.S. Department of Veterans Affairs to Biopool U.S., Inc., a subsidiary of Trinity Biotech PLC, for glycated hemoglobin (HbA1c) clinical reference laboratory services. The call order has a ceiling value of $95,657.75 and an ultimate completion date of November 21, 2020. The contract was awarded without a set-aside on November 22, 2019 under the Critical Analyzers, Laboratory (FSS-66-III) GSA schedule. Biopool U.S., Inc. has provided various...
- This contract was awarded to Biopool US, Inc., a foreign-owned, for-profit manufacturer and distributor of clinical laboratory diagnostics and testing equipment that does business as Trinity Biotech Distribution. The contract was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 19 on May 23, 2019 and has a potential value of $115,041.75. It is a BPA (Blanket Purchase Agreement) Call under the Critical Analyzers, Laboratory...
- The Department of Veterans Affairs Veterans Health Administration awarded a firm fixed price delivery order contract to Biopool US, Inc., a foreign-owned for-profit manufacturer and distributor of clinical laboratory diagnostics and testing equipment doing business as Trinity Biotech Distribution. The $22,230.00 contract is for the provision of glycohemoglobin analyzers, which are critical laboratory analyzers used to support quality healthcare and medical readiness programs. Biopool US, Inc....
- This federal contract award was issued by the Department of Veterans Affairs to Biopool U.S., Inc., a subsidiary of Trinity Biotech PLC, for the provision of service lab reagents for glycohemoglobin testing. The contract, which has a ceiling value of $429,024.90, was awarded on a firm fixed price basis. It is a delivery order contract under the Critical Analyzers, Laboratory (FSS-66-III) master schedule. The contract does not have a set-aside designation. Through this award, Biopool U.S., Inc....
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8 awarded a $12,918.36 firm fixed price delivery order contract to Biopool US, Inc., doing business as Trinity Biotech Distribution, for hemoglobin A1c control and proficiency testing from April 1, 2020 through September 30, 2020. As the parent company, Trinity Biotech PLC will support delivery of the requested products and services. This non-set aside award to the prime contractor will...
- Biopool U.S., Inc., doing business as Trinity Biotech Distribution, received a $6,394.64 firm fixed-price Purchase Order from the Department of Veterans Affairs' Veterans Integrated Service Network 21 for the "Ratification Test GHB Premier" contract. Awarded on January 1, 2024, with an ultimate completion date of December 3, 2025, this contract was not issued under a set-aside designation, indicating full and open competition. The place of performance is Reno, Nevada. Biopool U.S.,...
- Veterans Integrated Service Network 19, a civilian agency within the Department of Veterans Affairs, issued a BPA call to Biopool U.S., Inc. for hemoglobin A1C testing services on a cost-per-reportable-result basis, with a ceiling value of $36,771.85, awarded July 1, 2023. The call was designated as a Total Small Business set-aside. Place of performance is Jamestown, New York. The ultimate completion date is June 30, 2024. Biopool U.S., Inc. operates as Trinity Biotech Distribution and...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 7 awarded a $100,932.15 firm fixed price definitive contract to Biopool US, Inc., doing business as Trinity Biotech Distribution, on October 1, 2018 to provide coagulation cost per test services. The contract has a completion date of September 30, 2023 and was awarded without a set-aside designation in response to a solicitation posted on August 20, 2018 seeking these products and services....
- Veterans Integrated Service Network 19 issued a BPA call to Biopool U.S., Inc. under the GSA Critical Analyzers, Laboratory Federal Supply Schedule (FSS-66-III) on July 1, 2024, for hemoglobin A1c testing services on a cost-per-reportable-result basis, with a ceiling value of $40,254.09. The call was set aside for Total Small Business and performed in Jamestown, New York, with an ultimate completion date of June 30, 2025. Biopool U.S., Inc. operates as Trinity Biotech Distribution, a...
- This federal contract award is for the delivery of supplies and reagents for cost-per-test clinical laboratory services, awarded to Biopool U.S., Inc. by the U.S. Department of Veterans Affairs. The $139,301.94 firm fixed price contract is under the Critical Analyzers, Laboratory (FSS-66-III) GSA Schedule and has an ultimate completion date of February 23, 2022. Biopool U.S., Inc. is a subsidiary of the Ireland-based Trinity Biotech PLC, which has an established history of providing diagnostic...